|
|
40
|
|
|
A7512
|
|
|
SANDOSTATIN 0.1MG/ML INJ (NVS/COL) OCTREOTIDE
|
|
|
OCTREOTIDE
|
|
|
SANDOSTATIN
|
|
|
5X1ML
|
|
|
BQ
|
|
|
174.52
|
|
|
34.90
|
|
|
0.1MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
AMP
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
9292
|
|
|
OTHER THERAPEUTIC AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|